128 related articles for article (PubMed ID: 37029785)
21. Requirement of the MEK5-ERK5 pathway for neural differentiation in Xenopus embryonic development.
Nishimoto S; Kusakabe M; Nishida E
EMBO Rep; 2005 Nov; 6(11):1064-9. PubMed ID: 16179948
[TBL] [Abstract][Full Text] [Related]
22. Biochanin A protects against PM
Xue Z; Wang J; Yu W; Li D; Zhang Y; Wan F; Kou X
Food Funct; 2019 Nov; 10(11):7188-7203. PubMed ID: 31608342
[TBL] [Abstract][Full Text] [Related]
23. YAP promotes myogenic differentiation
Chen TH; Chen CY; Wen HC; Chang CC; Wang HD; Chuu CP; Chang CH
FASEB J; 2017 Jul; 31(7):2963-2972. PubMed ID: 28356344
[TBL] [Abstract][Full Text] [Related]
24. Ubiquitin-dependent regulation of MEKK2/3-MEK5-ERK5 signaling module by XIAP and cIAP1.
Takeda AN; Oberoi-Khanuja TK; Glatz G; Schulenburg K; Scholz RP; Carpy A; Macek B; Remenyi A; Rajalingam K
EMBO J; 2014 Aug; 33(16):1784-801. PubMed ID: 24975362
[TBL] [Abstract][Full Text] [Related]
25. MEK5 is activated by shear stress, activates ERK5 and induces KLF4 to modulate TNF responses in human dermal microvascular endothelial cells.
Clark PR; Jensen TJ; Kluger MS; Morelock M; Hanidu A; Qi Z; Tatake RJ; Pober JS
Microcirculation; 2011 Feb; 18(2):102-17. PubMed ID: 21166929
[TBL] [Abstract][Full Text] [Related]
26. ERK5 signalling in prostate cancer promotes an invasive phenotype.
Ramsay AK; McCracken SR; Soofi M; Fleming J; Yu AX; Ahmad I; Morland R; Machesky L; Nixon C; Edwards DR; Nuttall RK; Seywright M; Marquez R; Keller E; Leung HY
Br J Cancer; 2011 Feb; 104(4):664-72. PubMed ID: 21266977
[TBL] [Abstract][Full Text] [Related]
27. Oncogenic signaling of MEK5-ERK5.
Hoang VT; Yan TJ; Cavanaugh JE; Flaherty PT; Beckman BS; Burow ME
Cancer Lett; 2017 Apr; 392():51-59. PubMed ID: 28153789
[TBL] [Abstract][Full Text] [Related]
28. WNK1-TAK1 signaling suppresses lipopolysaccharide-induced cytokine production and classical activation in macrophages.
Arai Y; Asano K; Mandai S; Ando F; Susa K; Mori T; Nomura N; Rai T; Tanaka M; Uchida S; Sohara E
Biochem Biophys Res Commun; 2020 Dec; 533(4):1290-1297. PubMed ID: 33046244
[TBL] [Abstract][Full Text] [Related]
29. MEK5 and ERK5 are mediators of the pro-myogenic actions of IGF-2.
Carter EJ; Cosgrove RA; Gonzalez I; Eisemann JH; Lovett FA; Cobb LJ; Pell JM
J Cell Sci; 2009 Sep; 122(Pt 17):3104-12. PubMed ID: 19654213
[TBL] [Abstract][Full Text] [Related]
30. The Hedgehog-GLI Pathway Regulates MEK5-ERK5 Expression and Activation in Melanoma Cells.
Tusa I; Gagliardi S; Tubita A; Pandolfi S; Menconi A; Lulli M; Dello Sbarba P; Stecca B; Rovida E
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681917
[TBL] [Abstract][Full Text] [Related]
31. The MEK5/ERK5 Pathway in Health and Disease.
Paudel R; Fusi L; Schmidt M
Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299213
[TBL] [Abstract][Full Text] [Related]
32. A kinome-wide high-content siRNA screen identifies MEK5-ERK5 signaling as critical for breast cancer cell EMT and metastasis.
Pavan S; Meyer-Schaller N; Diepenbruck M; Kalathur RKR; Saxena M; Christofori G
Oncogene; 2018 Aug; 37(31):4197-4213. PubMed ID: 29713055
[TBL] [Abstract][Full Text] [Related]
33. Targeted Avenues for Cancer Treatment: The MEK5-ERK5 Signaling Pathway.
Pereira DM; Rodrigues CMP
Trends Mol Med; 2020 Apr; 26(4):394-407. PubMed ID: 32277933
[TBL] [Abstract][Full Text] [Related]
34. MEK5/ERK5 signaling mediates IL-4-induced M2 macrophage differentiation through regulation of c-Myc expression.
Luiz JPM; Toller-Kawahisa JE; Viacava PR; Nascimento DC; Pereira PT; Saraiva AL; Prado DS; LeBert M; Giurisato E; Tournier C; Cunha TM; Cunha FQ; Quesniaux V; Ryffel B; Alves-Filho JC
J Leukoc Biol; 2020 Oct; 108(4):1215-1223. PubMed ID: 32745297
[TBL] [Abstract][Full Text] [Related]
35. Pathophysiological Impact of the MEK5/ERK5 Pathway in Oxidative Stress.
Tusa I; Menconi A; Tubita A; Rovida E
Cells; 2023 Apr; 12(8):. PubMed ID: 37190064
[TBL] [Abstract][Full Text] [Related]
36. BAFF activation of the ERK5 MAP kinase pathway regulates B cell survival.
Jacque E; Schweighoffer E; Tybulewicz VL; Ley SC
J Exp Med; 2015 Jun; 212(6):883-92. PubMed ID: 25987726
[TBL] [Abstract][Full Text] [Related]
37. Upregulation of MEK5 by Stat3 promotes breast cancer cell invasion and metastasis.
Liu F; Zhang H; Song H
Oncol Rep; 2017 Jan; 37(1):83-90. PubMed ID: 27878304
[TBL] [Abstract][Full Text] [Related]
38. The MEK5/ERK5 mitogen-activated protein kinase cascade is an effector pathway of bone-sustaining bisphosphonates that regulates osteogenic differentiation and mineralization.
Adam C; Glück L; Ebert R; Goebeler M; Jakob F; Schmidt M
Bone; 2018 Jun; 111():49-58. PubMed ID: 29567200
[TBL] [Abstract][Full Text] [Related]
39. ERK5 and its role in tumour development.
Lochhead PA; Gilley R; Cook SJ
Biochem Soc Trans; 2012 Feb; 40(1):251-6. PubMed ID: 22260700
[TBL] [Abstract][Full Text] [Related]
40. WNK1-OSR1 Signaling Regulates Angiogenesis-Mediated Metastasis towards Developing a Combinatorial Anti-Cancer Strategy.
Hou CY; Ma CY; Lin YJ; Huang CL; Wang HD; Yuh CH
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292952
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
